Lyell Immunopharma Ownership | Who Owns Lyell Immunopharma?
Lyell Immunopharma Ownership Summary
Lyell Immunopharma is owned by 7.98% institutional investors, 18.72% insiders, and 73.30% retail investors. Arch venture management is the largest institutional shareholder, holding 18.65% of LYEL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.44% of its assets in Lyell Immunopharma shares.
LYEL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lyell Immunopharma | 7.98% | 18.72% | 73.30% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Arch venture management | 2.76M | 18.65% | $44.81M |
| Foresite capital management iv | 800.40K | 5.41% | $13.00M |
| Blackrock | 13.50M | 5.31% | $19.57M |
| Vanguard group | 779.00K | 5.27% | $12.65M |
| Almitas capital | 577.81K | 3.91% | $9.38M |
| Foresite capital management v | 477.08K | 3.23% | $7.75M |
| Venbio partners | 473.48K | 3.20% | $7.69M |
| Wuxi apptec | 7.68M | 3.02% | $11.14M |
| Alphabet | 293.26K | 1.98% | $4.76M |
| Blackrock funding, inc. /de | 176.81K | 1.20% | $2.87M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Wuxi apptec | 7.68M | 47.74% | $11.14M |
| Arch venture management | 2.76M | 9.10% | $44.81M |
| Foresite capital management v | 477.08K | 7.12% | $7.75M |
| Foresite capital management iv | 800.40K | 7.12% | $13.00M |
| Venbio partners | 473.48K | 4.36% | $7.69M |
| Almitas capital | 577.81K | 2.15% | $9.38M |
| Takeda pharmaceutical | 41.16K | 1.86% | $363.91K |
| Decheng capital | 595.47K | 1.33% | $5.26M |
| Mic capital management uk llp | 87.03K | 0.28% | $1.41M |
| Alphabet | 293.26K | 0.20% | $4.76M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Arch venture management | 2.76M | 9.10% | 938.44K |
| D. e. shaw | 966.26K | 0.00% | 493.64K |
| Wellington management group llp | 367.68K | 0.00% | 367.68K |
| Vanguard group | 779.00K | 0.00% | 336.38K |
| Millennium management | 957.51K | 0.00% | 247.44K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Decheng capital | 595.47K | 1.33% | -11.31M |
| Opaleye management | - | - | -1.40M |
| Balyasny asset management | - | - | -1.20M |
| Mwg management | - | - | -1.01M |
| Invenomic capital management lp | - | - | -871.52K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Wellington management group llp | 367.68K | 0.00% | 367.68K | $533.13K |
| Trexquant investment lp | 10.28K | 0.00% | 10.28K | $166.87K |
| Rangeley capital | 10.00K | 0.14% | 10.00K | $162.40K |
| Royal bank of canada | 4.19K | - | 4.19K | $68.00K |
| Macquarie group | 505.00 | - | 505.00 | $732.00 |
Sold Out
| Holder | Change |
|---|---|
| Eversource wealth advisors | -1.00 |
| Pnc financial services group | -4.00 |
| True wealth design | -23.00 |
| Nelson, van denburg & campbell wealth management group | -34.00 |
| Rothschild investment | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 15 | -78.26% | 1,180,540 | -87.25% | 7 | 0.20% | 6 | -50.00% | 4 | -92.86% |
| Jun 30, 2025 | 68 | -39.82% | 9,256,423 | -93.92% | 62 | 939.01% | 12 | -68.42% | 55 | 52.78% |
| Mar 31, 2025 | 112 | 8.74% | 152,309,719 | 1.35% | 51 | 1.50% | 38 | -26.92% | 37 | 48.00% |
| Dec 31, 2024 | 97 | -17.09% | 146,305,210 | 13.92% | 57 | 2.27% | 47 | -6.00% | 24 | -22.58% |
| Sep 30, 2024 | 117 | 0.86% | 128,424,945 | -3.67% | 50 | 1.82% | 51 | 4.08% | 31 | -27.91% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 276.12K | 1.44% | -6.10K |
| iShares Russell 2000 ETF | 4.13M | 1.39% | - |
| T. Rowe Price Health Sciences | 212.18K | 1.10% | -2.38K |
| Biotech Growth Ord | 2.88M | 0.99% | - |
| Vanguard Small Cap Index | 2.24M | 0.87% | 5.37K |
| iShares Russell 2000 Value ETF | 1.47M | 0.49% | - |
| Vanguard Small Cap Growth Index Inv | 1.25M | 0.49% | -5.54K |
| Vanguard Institutional Extnd Mkt Idx Tr | 91.69K | 0.48% | -37.12K |
| Fidelity Small Cap Index | 1.63M | 0.44% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 1.18M | 0.40% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 10, 2025 | Seely Lynn | President and CEO | Sell | $6.64K |
| Nov 10, 2025 | Bulis Veronica Sanchez | VP, Corporate Controller | Sell | $3.85K |
| Nov 10, 2025 | Lee Gary K. | Chief Scientific Officer | Sell | $2.23K |
| Nov 10, 2025 | Hill Stephen J. | Chief Operating Officer | Sell | $1.53K |
| Aug 21, 2025 | Seely Lynn | President and CEO | Sell | $76.52K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 12 |
| 2025 Q2 | - | - |
| 2025 Q1 | 5 | - |
| 2024 Q4 | - | - |
LYEL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools